Back to Agenda
Session 3 (continued): Research and Related Initiatives to Evaluate and Improve Real-World Evidence and Real-World Data
Session Chair(s)
John Concato, MD, MPH, MS
Associate Director for Real-World Evidence Analytics, OMP, CDER, FDA, United States
Delphine Saragoussi, MD, MSC
Head of Pharmacoepidemiology Vaccines, Sanofi, France
Part 2: Continue the discussion now focusing on regulatory agency perspective.
Speaker(s)
Kenneth Quinto, MD, MPH
Senior Medical Advisor for Real World Evidence Analytics, OMP, CDER, FDA, United States
Speakers
Laura Esserman, MD, MBA
Director, Breast Care Center; Professor of Surgery and Radiology, UCSF, United States
Speaker
Michele Jonsson Funk, PHD, FISPE
Associate Professor of Epidemiology; Director, Center for Pharmacoepidemiology, University of North Carolina at Chapel Hill, United States
Speaker
Catherine Cohet, PHD
Senior Pharmacoepidemiologist, Data Analytics and Methods Task Force, European Medicines Agency, Netherlands
Speaker
Have an account?